Opioid Induced Side Effects Treatment Market 2027 By Product Type, Application, Distribution Channel | The Insight Partners

Opioid Induced Side Effects Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Antihistamines, Antipsychotics, Prokinetic Agents, Central Nervous System (CNS) Stimulant, Laxative, Other); Application (Drug Overdose Treatment, Pain Treatment, Other); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00015281 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Opioids are used to treat chronic as well as acute pain among the patients. Side-effects associated with opioid administration are dizziness, sedation, vomiting, nausea, physical dependence, constipation, tolerance, and respiratory depression. Antihistamines, antipsychotics and other types of drugs are used to reduce the side effects of opioids

MARKET DYNAMICS

The key factors driving the growth of the opioid induced side effects treatment market are increasing prevalence of chronic diseases like cancer, postsurgical pain, arthritis and others, increasing prescription of opioids, and advanced healthcare infrastructure. However, deaths due to drug over dose is likely to hamper the growth of the market.

MARKET SCOPE

The "Opioid Induced Side Effects Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of opioid induced side effects treatment market with detailed market segmentation by product type, application, and distribution channel. The opioid induced side effects treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Opioid Induced Side Effects Treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The opioid induced side effects treatment market is segmented on the basis of product type, application, and distribution channel. Based on product type, the market is segmented antihistamines, antipsychotics, prokinetic agents, central nervous system (CNS) stimulant, laxative, and other. Based on application the market is segmented into drug overdose treatment, pain treatment, and other. The distribution channel market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Opioid Induced Side Effects Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Induced Side Effects Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Opioid Induced Side Effects Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Induced Side Effects Treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Opioid Induced Side Effects Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Opioid Induced Side Effects Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Opioid Induced Side Effects Treatment in the global market. Below mentioned is the list of few companies engaged in the Opioid Induced Side Effects Treatment market.

The report also includes the profiles of key players in Opioid Induced Side Effects Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Astrazeneca PLC
  •   S.L.A. Pharma AG
  •   Shionogi And CO., LTD.
  •   Cubist Pharmaceuticals, Inc
  •   Progenics Pharmaceuticals, Inc
  •   Aiko Biotechnology, Inc
  •   Theravance Biopharma Inc
  •   Valeant Pharmaceuticals International
  •   Cosmo Pharmaceuticals S.A
  •   Merck and Co. Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Opioid Induced Side Effects Treatment Market - By Product Type
1.3.2 Opioid Induced Side Effects Treatment Market - By Application
1.3.3 Opioid Induced Side Effects Treatment Market - By Distribution Channel
1.3.4 Opioid Induced Side Effects Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. OPIOID INDUCED SIDE EFFECTS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. OPIOID INDUCED SIDE EFFECTS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIHISTAMINES
7.3.1. Overview
7.3.2. Antihistamines Market Forecast and Analysis
7.4. ANTIPSYCHOTICS
7.4.1. Overview
7.4.2. Antipsychotics Market Forecast and Analysis
7.5. PROKINETIC AGENTS
7.5.1. Overview
7.5.2. Prokinetic Agents Market Forecast and Analysis
7.6. CENTRAL NERVOUS SYSTEM (CNS) STIMULANT
7.6.1. Overview
7.6.2. Central Nervous System (CNS) Stimulant Market Forecast and Analysis
7.7. LAXATIVE
7.7.1. Overview
7.7.2. Laxative Market Forecast and Analysis
7.8. OTHER
7.8.1. Overview
7.8.2. Other Market Forecast and Analysis
8. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG OVERDOSE TREATMENT
8.3.1. Overview
8.3.2. Drug Overdose Treatment Market Forecast and Analysis
8.4. PAIN TREATMENT
8.4.1. Overview
8.4.2. Pain Treatment Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Opioid Induced Side Effects Treatment Market Overview
10.1.2 North America Opioid Induced Side Effects Treatment Market Forecasts and Analysis
10.1.3 North America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Product Type
10.1.4 North America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Application
10.1.5 North America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Opioid Induced Side Effects Treatment Market
10.1.6.1.1 United States Opioid Induced Side Effects Treatment Market by Product Type
10.1.6.1.2 United States Opioid Induced Side Effects Treatment Market by Application
10.1.6.1.3 United States Opioid Induced Side Effects Treatment Market by Distribution Channel
10.1.6.2 Canada Opioid Induced Side Effects Treatment Market
10.1.6.2.1 Canada Opioid Induced Side Effects Treatment Market by Product Type
10.1.6.2.2 Canada Opioid Induced Side Effects Treatment Market by Application
10.1.6.2.3 Canada Opioid Induced Side Effects Treatment Market by Distribution Channel
10.1.6.3 Mexico Opioid Induced Side Effects Treatment Market
10.1.6.3.1 Mexico Opioid Induced Side Effects Treatment Market by Product Type
10.1.6.3.2 Mexico Opioid Induced Side Effects Treatment Market by Application
10.1.6.3.3 Mexico Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Opioid Induced Side Effects Treatment Market Overview
10.2.2 Europe Opioid Induced Side Effects Treatment Market Forecasts and Analysis
10.2.3 Europe Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Product Type
10.2.4 Europe Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Application
10.2.5 Europe Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Opioid Induced Side Effects Treatment Market
10.2.6.1.1 Germany Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.1.2 Germany Opioid Induced Side Effects Treatment Market by Application
10.2.6.1.3 Germany Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2.6.2 France Opioid Induced Side Effects Treatment Market
10.2.6.2.1 France Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.2.2 France Opioid Induced Side Effects Treatment Market by Application
10.2.6.2.3 France Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2.6.3 Italy Opioid Induced Side Effects Treatment Market
10.2.6.3.1 Italy Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.3.2 Italy Opioid Induced Side Effects Treatment Market by Application
10.2.6.3.3 Italy Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2.6.4 Spain Opioid Induced Side Effects Treatment Market
10.2.6.4.1 Spain Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.4.2 Spain Opioid Induced Side Effects Treatment Market by Application
10.2.6.4.3 Spain Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Opioid Induced Side Effects Treatment Market
10.2.6.5.1 United Kingdom Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.5.2 United Kingdom Opioid Induced Side Effects Treatment Market by Application
10.2.6.5.3 United Kingdom Opioid Induced Side Effects Treatment Market by Distribution Channel
10.2.6.6 Rest of Europe Opioid Induced Side Effects Treatment Market
10.2.6.6.1 Rest of Europe Opioid Induced Side Effects Treatment Market by Product Type
10.2.6.6.2 Rest of Europe Opioid Induced Side Effects Treatment Market by Application
10.2.6.6.3 Rest of Europe Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Overview
10.3.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Opioid Induced Side Effects Treatment Market
10.3.6.1.1 Australia Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.1.2 Australia Opioid Induced Side Effects Treatment Market by Application
10.3.6.1.3 Australia Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3.6.2 China Opioid Induced Side Effects Treatment Market
10.3.6.2.1 China Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.2.2 China Opioid Induced Side Effects Treatment Market by Application
10.3.6.2.3 China Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3.6.3 India Opioid Induced Side Effects Treatment Market
10.3.6.3.1 India Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.3.2 India Opioid Induced Side Effects Treatment Market by Application
10.3.6.3.3 India Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3.6.4 Japan Opioid Induced Side Effects Treatment Market
10.3.6.4.1 Japan Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.4.2 Japan Opioid Induced Side Effects Treatment Market by Application
10.3.6.4.3 Japan Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3.6.5 South Korea Opioid Induced Side Effects Treatment Market
10.3.6.5.1 South Korea Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.5.2 South Korea Opioid Induced Side Effects Treatment Market by Application
10.3.6.5.3 South Korea Opioid Induced Side Effects Treatment Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Opioid Induced Side Effects Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Opioid Induced Side Effects Treatment Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Opioid Induced Side Effects Treatment Market by Application
10.3.6.6.3 Rest of Asia-Pacific Opioid Induced Side Effects Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Opioid Induced Side Effects Treatment Market Overview
10.4.2 Middle East and Africa Opioid Induced Side Effects Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Opioid Induced Side Effects Treatment Market
10.4.6.1.1 South Africa Opioid Induced Side Effects Treatment Market by Product Type
10.4.6.1.2 South Africa Opioid Induced Side Effects Treatment Market by Application
10.4.6.1.3 South Africa Opioid Induced Side Effects Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Opioid Induced Side Effects Treatment Market
10.4.6.2.1 Saudi Arabia Opioid Induced Side Effects Treatment Market by Product Type
10.4.6.2.2 Saudi Arabia Opioid Induced Side Effects Treatment Market by Application
10.4.6.2.3 Saudi Arabia Opioid Induced Side Effects Treatment Market by Distribution Channel
10.4.6.3 U.A.E Opioid Induced Side Effects Treatment Market
10.4.6.3.1 U.A.E Opioid Induced Side Effects Treatment Market by Product Type
10.4.6.3.2 U.A.E Opioid Induced Side Effects Treatment Market by Application
10.4.6.3.3 U.A.E Opioid Induced Side Effects Treatment Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Opioid Induced Side Effects Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Opioid Induced Side Effects Treatment Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Opioid Induced Side Effects Treatment Market by Application
10.4.6.4.3 Rest of Middle East and Africa Opioid Induced Side Effects Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Opioid Induced Side Effects Treatment Market Overview
10.5.2 South and Central America Opioid Induced Side Effects Treatment Market Forecasts and Analysis
10.5.3 South and Central America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Application
10.5.5 South and Central America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Opioid Induced Side Effects Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Opioid Induced Side Effects Treatment Market
10.5.6.1.1 Brazil Opioid Induced Side Effects Treatment Market by Product Type
10.5.6.1.2 Brazil Opioid Induced Side Effects Treatment Market by Application
10.5.6.1.3 Brazil Opioid Induced Side Effects Treatment Market by Distribution Channel
10.5.6.2 Argentina Opioid Induced Side Effects Treatment Market
10.5.6.2.1 Argentina Opioid Induced Side Effects Treatment Market by Product Type
10.5.6.2.2 Argentina Opioid Induced Side Effects Treatment Market by Application
10.5.6.2.3 Argentina Opioid Induced Side Effects Treatment Market by Distribution Channel
10.5.6.3 Rest of South and Central America Opioid Induced Side Effects Treatment Market
10.5.6.3.1 Rest of South and Central America Opioid Induced Side Effects Treatment Market by Product Type
10.5.6.3.2 Rest of South and Central America Opioid Induced Side Effects Treatment Market by Application
10.5.6.3.3 Rest of South and Central America Opioid Induced Side Effects Treatment Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. OPIOID INDUCED SIDE EFFECTS TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ASTRAZENECA PLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. S.L.A. PHARMA AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SHIONOGI AND CO., LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CUBIST PHARMACEUTICALS, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PROGENICS PHARMACEUTICALS, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AIKO BIOTECHNOLOGY, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. THERAVANCE BIOPHARMA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. VALEANT PHARMACEUTICALS INTERNATIONAL
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. COSMO PHARMACEUTICALS S.A.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERCK AND CO. INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Astrazeneca PLC
2. S.L.A. Pharma AG
3. Shionogi And CO., LTD.
4. Cubist Pharmaceuticals, Inc
5. Progenics Pharmaceuticals, Inc
6. Aiko Biotechnology, Inc
7. Theravance Biopharma Inc
8. Valeant Pharmaceuticals International
9. Cosmo Pharmaceuticals S.A
10. Merck and Co. Inc
TIPRE00015281
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking